Hormonal
Lisdexamfetamine dimesylate is the only FDA-approved medication for Binge Eating Disorder and significantly reduces binge eating days and increases binge cessation rates compared to placebo.
Lisdexamfetamine is the only FDA-approved medication for Binge Eating Disorder. Clinical trials show it significantly reduces binge eating days and increases the likelihood of stopping binges compared to a placebo. However, because it is a stimulant, it requires caution in patients with T2DM who may also have hypertension or cardiovascular issues. Discuss the risks and benefits with your doctor if you are considering medication.
The only current Food and Drug Administration (FDA) approved medication for the treatment of BED is the stimulant lisdexamfetamine... the medication decreased binge eating days, binge-eating related obsessions and compulsions, and more frequently resulted in binge cessation than placebo.
Why this rating
Supported by multiple multicenter, double-blind trials and meta-analyses.
Source
<p>Binge Eating Disorder in Patients with Type 2 Diabetes: Diagnostic and Management Challenges</p>
Jonathan D Chevinsky et al. · Diabetes Metabolic Syndrome and Obesity · 2020
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →